Health Canada
NOTICE
Health Canada revises approach for granting extensions to responses to notices of deficiency and non-compliance for generic drug submissions: Notice
Published: 9/1/2026Detected: 9/4/2026
Summary preview
Revises Health Canada’s approach to granting extensions for generic drug submissions in response to notices of deficiency and non-compliance, potentially tightening or clarifying how and when applicants can request…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
#Health Canada
#generic drug submissions
#notice of deficiency
#non-compliance
#extensions
Official Source Document Source Verified
Access the original document directly from HEALTH CANADA.
More from Health Canada
- Advisory Committee: Review of the Federal Approach to Pandemic Science Advice and Research Coordination10/2/2026
- Advisory Committee: National Pharmacare Committee of Experts10/2/2026
- Advisory Committee: Ministerial Advisory Council on Mental Health10/2/2026
- Advisory Committee: Expert Task Force on Substance Use10/2/2026
- Advisory Committee: Expert Panel on MAID and Mental Illness10/2/2026